| Primary |
| Irritable Bowel Syndrome |
50.0% |
| Abdominal Discomfort |
16.7% |
| Abdominal Pain |
16.7% |
| Dyspepsia |
16.7% |
|
| Drug Ineffective |
14.3% |
| Physical Product Label Issue |
14.3% |
| Product Quality Issue |
14.3% |
| Skin Exfoliation |
14.3% |
| Tachycardia |
14.3% |
| Urticaria |
14.3% |
| Visual Acuity Reduced |
14.3% |
|
| Secondary |
| Diarrhoea |
40.0% |
| Irritable Bowel Syndrome |
20.0% |
| Bone Disorder |
10.0% |
| Ex-smoker |
10.0% |
| Smoking Cessation Therapy |
10.0% |
| Abdominal Pain |
5.0% |
| Fibromyalgia |
5.0% |
|
| Drug Hypersensitivity |
29.4% |
| Dry Eye |
11.8% |
| Viral Infection |
11.8% |
| Colitis |
5.9% |
| Convulsion |
5.9% |
| Diarrhoea |
5.9% |
| Dry Mouth |
5.9% |
| Pain |
5.9% |
| Rash |
5.9% |
| Rectal Discharge |
5.9% |
| Weight Decreased |
5.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.1% |
| Drug Use For Unknown Indication |
13.6% |
| Pain |
7.1% |
| Crohn's Disease |
6.7% |
| Depression |
4.5% |
| Osteoporosis |
4.4% |
| Gastrooesophageal Reflux Disease |
3.9% |
| Abdominal Pain |
3.5% |
| Hypertension |
3.4% |
| Contraception |
3.1% |
| Systemic Lupus Erythematosus |
3.1% |
| Migraine |
2.9% |
| Anxiety |
2.8% |
| Nausea |
2.6% |
| Blood Pressure |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Irritable Bowel Syndrome |
2.2% |
| Constipation |
2.1% |
| Breast Cancer |
1.9% |
| Asthma |
1.4% |
|
| Wound Infection Staphylococcal |
11.7% |
| Vomiting |
10.2% |
| Weight Decreased |
10.2% |
| Pain |
6.6% |
| Weight Increased |
6.6% |
| Drug Ineffective |
6.1% |
| Vision Blurred |
5.1% |
| Urinary Incontinence |
4.6% |
| Wound Dehiscence |
4.1% |
| Somnolence |
3.6% |
| Vitamin D Decreased |
3.6% |
| Abdominal Pain |
3.1% |
| Cholelithiasis |
3.1% |
| Hyperglycaemia |
3.1% |
| Ileus |
3.1% |
| Pain In Extremity |
3.1% |
| Palpitations |
3.1% |
| Rash |
3.1% |
| Rectal Haemorrhage |
3.1% |
| Thermal Burn |
3.1% |
|
